Literature DB >> 18474734

Neurological complications of herpes simplex virus type 2 infection.

Joseph R Berger1, Sidney Houff.   

Abstract

Herpes simplex virus type 2 (HSV-2) infection is responsible for significant neurological morbidity, perhaps more than any other virus. Seroprevalence studies suggest that as many as 45 million people in the United States have been infected with HSV-2, and the estimated incidence of new infection is 1 million annually. Substantial numbers of these persons will manifest neurological symptoms that are generally, although not always, mild and self-limited. Despite a 50% genetic homology between HSV-1 and HSV-2, there are significant differences in the clinical manifestations of these 2 viruses. We herein review the neurological complications of HSV-2 infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18474734     DOI: 10.1001/archneur.65.5.596

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  33 in total

1.  Encephalitis with herpes simplex-2 in the cerebrospinal fluid and anti-RI (ANNA-2) antibodies: an infectious or a paraneoplastic syndrome?

Authors:  Jan Novy; Antonio Carota; Philippe Eggimann; Marc Pusztaszeri; Andrea O Rossetti; Renaud Du Pasquier
Journal:  BMJ Case Rep       Date:  2009-08-11

Review 2.  Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management.

Authors:  Jocelyne Piret; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

3.  Genital herpes simplex virus type 2 infection in humanized HIV-transgenic mice triggers HIV shedding and is associated with greater neurological disease.

Authors:  Briana Nixon; Esra Fakioglu; Martha Stefanidou; Yanhua Wang; Monica Dutta; Harris Goldstein; Betsy C Herold
Journal:  J Infect Dis       Date:  2013-08-29       Impact factor: 5.226

4.  Disseminated HSV-2 presenting with relapsing encephalomyelitis.

Authors:  Clotilde Hainline; Dominique Rosales; Purvi Parikh; Eddie Louie; Jonathan Howard; Nina Kim; Steven L Galetta
Journal:  Neurol Clin Pract       Date:  2016-12

5.  Herpes Simplex Virus 2 in Autonomic Ganglia: Evidence for Spontaneous Reactivation.

Authors:  Julianna R Pieknik; Andrea S Bertke; Philip R Krause
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

6.  Rapid and direct detection of herpes simplex virus in cerebrospinal fluid by use of a commercial real-time PCR assay.

Authors:  Matthew J Binnicker; Mark J Espy; Cole L Irish
Journal:  J Clin Microbiol       Date:  2014-10-01       Impact factor: 5.948

7.  Natalizumab and HSV meningitis.

Authors:  Erica Seiguer Shenoy; Eleftherios Mylonakis; Rocio M Hurtado; Nagagopal Venna
Journal:  J Neurovirol       Date:  2011-04-13       Impact factor: 2.643

8.  Herpes simplex virus 2 meningitis: a retrospective cohort study.

Authors:  Stephanie Miller; Farrah J Mateen; Allen J Aksamit
Journal:  J Neurovirol       Date:  2013-03-15       Impact factor: 2.643

9.  Herpes simplex virus meningitis complicated by ascending paralysis.

Authors:  Mina M Benjamin; Kyle L Gummelt; Rabeea Zaki; Aasim Afzal; Louis Sloan; Sadat Shamim
Journal:  Proc (Bayl Univ Med Cent)       Date:  2013-07

Review 10.  Update on herpes virus infections of the nervous system.

Authors:  Israel Steiner; Felix Benninger
Journal:  Curr Neurol Neurosci Rep       Date:  2013-12       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.